Zdrowie i gospodarka · 27/10/2021
FDA Proposes Exemption of Certain Biological Products From Reporting Requirements
The FDA is proposing to exempt two categories of biological products from annual reporting requirements under the FD&C Act, citing that public health protection is not necessary for these products.
Source: Federal Register — Food and Drug AdministrationOpen original release →